Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution.
BMC Cancer
; 22(1): 119, 2022 Jan 29.
Article
in En
| MEDLINE
| ID: mdl-35093003
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Neoadjuvant Therapy
/
Radiotherapy, Intensity-Modulated
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2022
Type:
Article